BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15897303)

  • 1. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
    Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
    Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis.
    Röcken C; Fändrich M; Stix B; Tannert A; Hortschansky P; Reinheckel T; Saftig P; Kähne T; Menard R; Ancsin JB; Bühling F
    J Pathol; 2006 Dec; 210(4):478-87. PubMed ID: 17068745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L.
    Bohne S; Sletten K; Menard R; Bühling F; Vöckler S; Wrenger E; Roessner A; Röcken C
    J Pathol; 2004 May; 203(1):528-37. PubMed ID: 15095475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationship between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis.
    Phipps-Yonas H; Pinard G; Ali-Khan Z
    Scand J Immunol; 2004 Feb; 59(2):168-76. PubMed ID: 14871293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin D activity protects against development of type AA amyloid fibrils.
    van der Hilst JC; Kluve-Beckerman B; van der Meer JW; Simon A
    Eur J Clin Invest; 2009 May; 39(5):412-6. PubMed ID: 19740371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.
    Westermark GT; Sletten K; Grubb A; Westermark P
    Am J Pathol; 1990 Aug; 137(2):377-83. PubMed ID: 2386201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
    Liepnieks JJ; Kluve-Beckerman B; Benson MD
    Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats.
    Tei M; Uchida K; Chambers JK; Watanabe KI; Tamamoto T; Ohno K; Nakayama H
    J Vet Med Sci; 2018 Feb; 80(1):164-172. PubMed ID: 29199213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation and absorption of serum amyloid A and apolipoprotein E fragments in the course of AA amyloidosis: a study in a mouse model.
    Sato J; Kotani K; Yamada T
    Ann Clin Lab Sci; 2014; 44(3):249-53. PubMed ID: 25117094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A putative role for cathepsin K in degradation of AA and AL amyloidosis.
    Röcken C; Stix B; Brömme D; Ansorge S; Roessner A; Bühling F
    Am J Pathol; 2001 Mar; 158(3):1029-38. PubMed ID: 11238051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.
    Hol PR; van Ederen AM; Snel FW; Langeveld JP; Veerkamp JH; Gruys E
    Br J Exp Pathol; 1985 Jun; 66(3):279-92. PubMed ID: 2860918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.
    Munger JS; Haass C; Lemere CA; Shi GP; Wong WS; Teplow DB; Selkoe DJ; Chapman HA
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):299-305. PubMed ID: 7575468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.
    Hook V; Funkelstein L; Wegrzyn J; Bark S; Kindy M; Hook G
    Biochim Biophys Acta; 2012 Jan; 1824(1):89-104. PubMed ID: 21925292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of highly prevalent amyloid A amyloidosis endemic to endangered island foxes.
    Gaffney PM; Imai DM; Clifford DL; Ghassemian M; Sasik R; Chang AN; O'Brien TD; Coppinger J; Trejo M; Masliah E; Munson L; Sigurdson C
    PLoS One; 2014; 9(11):e113765. PubMed ID: 25429466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.
    Jayaraman S; Gantz DL; Haupt C; Gursky O
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6507-E6515. PubMed ID: 28743750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation.
    Yamada T; Kluve-Beckerman B; Liepnieks JJ; Benson MD
    Scand J Immunol; 1995 Jun; 41(6):570-4. PubMed ID: 7770727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
    Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
    Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.